| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
2,863 |
2,509 |
$89K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
927 |
910 |
$77K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,113 |
1,040 |
$69K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
749 |
713 |
$39K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,278 |
1,127 |
$32K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
201 |
196 |
$14K |
| 90688 |
|
409 |
390 |
$4K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
596 |
568 |
$4K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
332 |
162 |
$4K |
| 90677 |
|
200 |
195 |
$3K |
| 90670 |
|
323 |
310 |
$3K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
193 |
188 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
256 |
208 |
$2K |
| 90698 |
|
154 |
149 |
$2K |
| 90680 |
|
150 |
148 |
$2K |
| 90697 |
|
82 |
82 |
$820.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
20 |
20 |
$674.31 |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
13 |
13 |
$469.96 |
| 87807 |
|
41 |
35 |
$451.85 |
| 92552 |
|
50 |
50 |
$376.00 |
| 99173 |
|
70 |
66 |
$357.00 |
| 90633 |
|
24 |
24 |
$240.00 |
| 96127 |
|
39 |
39 |
$154.46 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
17 |
16 |
$0.00 |